Completed

NCT Number: NCT01848782

Impact of Adding a Limitation Section in Abstract of Systematic Review

Objective: The investigators aim to evaluate the impact of a adding a " limitations " section in systematic review's abstract on result's interpretation by readers Design: randomized controlled trial with two parallel arms. Participants will be invited to participate in an online survey.

Participants: Eligible participants are corresponding authors of clinical trials published between 2010 and 2012 and referenced in Medline.

Intervention: The investigators will evaluate the impact of the presence of a " limitations " section in abstract of systematic review with meta- analysis. The investigators selected abstracts of meta-analysis from a sample.

Selected abstract will be standardised and the treatment's name hidden. Two groups of abstract will be presented as follow: 1) abstract without " limitations " section 2) abstract with " limitations " section. The " limitations " section will be written by authors and will briefly describe the risk of bias of included studies.

Selected participant are invited by e-mail to answer the survey. After reading one abstract from his/her group of randomisation they are invited to answer 5 questions about their interpretation of the results.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Systematic Review

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Paris, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

corresponding authors of clinical trail indexed in pubmed with email address available

Treatment and study plan

interpretation of the abstract of the systematic review

Behavioral

Primary outcomes

Confidence in the Results of the Systematic Review

Time frame: 1 month

we ask participants: "how confident are you in the results of this study?", with the choice of answer based on a 10 points Likert scale (score from 0, not at all confident, to 10, very confident )

Secondary outcomes

Confidence With the Validity of the Conclusions

Time frame: 1 month
We ask participants:
- "How confident are you in the validity of the conclusions of this study?"
with the choice of answer based on a 10 points Likert scale from 0, not at all confident, to 10, very confident
Beneficial Effect of the Experimental Intervention

Time frame: 1 month
We ask participants:
- "How confident are you that the intervention "A" could be of benefit to patients?"
with the choice of answer based on a 10 points Likert scale from 0, not at all confident, to 10, very confident
Influence of Results on Clinical Practice

Time frame: 1 month

We ask participants:

"How confident are you that the results of this study could influence your clinical practice?" with the choice of answer based on a 10 points Likert scale from 0, not at all confident, to 10, very confident
The Rigor of the Systematic Review

Time frame: 1 month

We ask participants:

"Do you think that this systematic review was conducted rigorously?" with the choice of answer based on a 10 points Likert scale from 0, not at all confident, to 10, very confident

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Registry information

Official study title

Impact of Adding a Limitation Section in Abstract of Systematic Review on Interpretation by Readers: a Randomised Controlled Trial

Acronym: ILMARI2

Important dates

Study start: 2013
Primary completion: 2013
Study completion: 2013
First posted: May 8, 2013
Registry last updated: May 17, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.